drugset
drugset / Trial / NCT01069861

Study To Investigate Safety And Efficacy Of Sildenafil In The Newborns With Persistent Pulmonary Hypertension (PPHN)

NCT01069861 ↗

Phase 2 Terminated 4 enrolled Viatris Inc.
NaSingle-groupOpen-labelTreatment

Summary

Sildenafil is efficacious in newborns with persistent pulmonary hypertension and its use will reduce the need for inhaled nitric oxide.

Timeline

Start
2010-12
Primary completion
2011-11
Completion
2011-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Sildenafil Unknown 0.03 mg/kg Intravenous

Indications

pulmonary hypertension, neonatal respiratory failure